Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	10.58	40.92	37.00
Graham Fair Price	5.69	2.78	2.63
PEG	73.40	2.74	1.58
Price/Book	-13.13	1.46	1.68
Price/Cash Flow	-38.11	15.79	25.52
Prices/Earnings	-12.99	15.42	17.72
Price/Sales	-22.58	2.56	3.30
Price/FCF	-38.11	15.79	25.52
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-18.47	0.11	0.14
Operating Margin	9.89	0.06	0.05
ROA	-1.89	0.01	0.01
ROE	0.02	0.02	-0.17
ROIC	0.02	0.02	-9.01
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.24	-0.11	119.41
Dividends QOQ	0.21	-0.17	-21.01
EBIT QOQ	-0.11	0.23	103.89
EPS QOQ	0.11	0.06	-49.82
FCF QOQ	2.12	0.40	-80.99
Revenue QOQ	-0.03	0.12	272.04
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	63.78	38.87	-39.05
Days Sales Outstanding (DSO)	65.50	55.42	-15.39
Inventory Turnover	1.41	2.32	64.08
Debt/Capitalization	0.29	0.33	15.71
Quick Ratio	1.20	1.34	11.99
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.60	3.81	5.78
Cash	1.61	2.30	42.55
Capex	-0.04	-0.09	-130.33
Free Cash Flow	0.24	0.35	48.47
Revenue	1.83	2.17	18.69
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.87	1.82	-2.57
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.72	-2.01	-177.82
Naive Interpretation	Member

06 - Financial Health · Weak

Rating